Source: Cyntegrity Blog

Cyntegrity Blog Machine Learning-Based Predictions for All Clinical Research Metrics

MyRBQM® Portal's new Machine Learning predictive analytics model is far less sensitive to noise, it better generalizes data, and provides narrower CIs in long time series. Singular Spectrum Analysis is particularly valuable for long time series, as mostly observed in clinical trials.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Artem Andrianov's photo - Founder & CEO of Cyntegrity

Founder & CEO

Artem Andrianov

CEO Approval Rating

70/100

Cyntegrity Germany is a developer, builder and provider of risk-based monitoring products for clinical trials. Read more